Peripheral insulin resistance could promote AD onset by reducing brain insulin uptake and by raising brain levels of Aβ, tau phosphorylation, oxidative stress, proinflammatory cytokines, advanced glycation end products, dyslipidemia, and apoptosis (Talbot et al., 2012). The gene discussed is INS; the disease is Alzheimer disease.